查看“靶向药行业研究”的源代码


[[category:行业研究]]
<div style="max-width:73%;
	background-color:#C1FFC1;
	border:0px solid #000000;">
#史上最全癌症靶向药（2017版）  https://mp.weixin.qq.com/s/7mpVHYy4QV8DZZFrU5Nc8w
#Overview of Targeted Therapies for Cancer - My Cancer Genome  https://www.mycancergenome.org/content/molecular-medicine/overview-of-targeted-therapies-for-cancer
#New FDA Approved Drugs for 2017 | CenterWatch  http://www.centerwatch.com/drug-information/fda-approved-drugs/
#A to Z List of Cancer Drugs - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs
===淋巴瘤===
#Ibrutinib（依鲁替尼），靶点BTK，Ibrutinib (PCI-32765) | BTK 抑制剂  http://www.selleck.cn/products/pci-32765.html Ibrutinib - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/ibrutinib
#Ibritumomab tiuxetan（替伊莫单抗），靶点CD20，抗癌新药Zevalin（ibritumomab tiuxetan）获FDA批准用于非何杰金氏淋巴瘤 - 诺本专科新特药房  http://www.nbdyf.com/zhongliuke/61.html   Ibritumomab Tiuxetan - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/ibritumomabtiuxetan
#Rituximab（利妥昔单抗），靶点CD20，中国已经上市，Rituximab - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/rituximab
#Tositumomab（托西莫单抗）,靶点CD20，Tositumomab and Iodine I 131 Tositumomab - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/tositumomab-I131tositumomab
#Obinutuzumab（奥滨尤妥珠单抗），靶点CD20，Obinutuzumab - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/obinutuzumab GAZYVA(obinutuzumab 中文名：奥滨尤妥珠单抗)注射剂_海得康海外新特药  http://www.headkonmed.com/headkonmed/products/2923118.html
#Brentuximab vedotin（本妥昔单抗），靶点CD30，Brentuximab Vedotin - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/brentuximabvedotin
#Romidepsin（罗米地辛），靶点HDAC，Romidepsin - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/romidepsin
#Vorinostat（伏立诺他），靶点HDAC，Vorinostat - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/vorinostat
#Belinostat，靶点HDAC，Belinostat - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/belinostat
#Idelalisib，靶点PI3Kδ，Idelalisib - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/idelalisib
#Nivolumab（纳武单抗），靶点PD-1，Nivolumab - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/nivolumab
#Pembrolizumab（派姆单抗），靶点PD-1，Pembrolizumab - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/pembrolizumab
#Bortezomib（硼替佐米），靶点Proteasome，中国已经上市 Bortezomib - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/bortezomib
</div>